WebDisclosure WebDisclosure
Basculer en Français
11364 Companies
252471 Keywords
181962 Articles
138269 Press releases
Headlines Articles Press releases MDM Permian, Inc. Remove
  1. Home
  2. Companies
  3. MDM Permian, Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 08/29/2023 at 19:00, 3 years 2 months ago

    MDM Permian Inc Celebrates Milestone: Successful Sale of First Load of Oil from East Texas Acquisition

    Logo of MDM Permian, Inc.
  • PRESS RELEASE

    published on 08/23/2023 at 21:50, 3 years 2 months ago

    MDM Permian, Inc. (Symbol:MDMP) Announces Strategic Acquisitions and Strengthened Management

    Logo of MDM Permian, Inc.
  • PRESS RELEASE

    published on 06/29/2023 at 18:25, 3 years 4 months ago

    MDM Permian, Inc. (Symbol: MDMP) Acquires a 90% working interest in a 640-Acre Lease in the East Texas Basin

    Logo of MDM Permian, Inc.
Previous page
1 2
Accesswire
  • Published on 11/17/2026 at 23:40, 31 minutes ago

    AI/ML Innovations Inc. Closes First Tranche of Private Placement

  • Published on 11/17/2026 at 23:00, 1 hour 11 minutes ago

    Alset AI Ventures Inc. Announces Extension of Annual General Meeting Deadline

  • Published on 11/17/2026 at 21:30, 2 hours 41 minutes ago

    Fairplay Ventures INC. Announces Filing of Filing Statement in Connection With Qualifying Transaction

  • Published on 11/17/2026 at 15:00, 9 hours 11 minutes ago

    Secure Blockchain's Agentic Solutions Signs Engineering Company, Expanding Enterprise AI Into Heavy Industry

  • Published on 11/17/2026 at 14:45, 9 hours 26 minutes ago

    NanoViricides, Inc. Has Filed its Quarterly Report - Broad-Spectrum Antiviral Drug NV-387 Oral Gummies Has Entered Two Separate Phase II Clinical Trials - One to Treat Ebola Bundibugyo Virus Disease, and Another to Treat Mpox (Monkeypox)

View all ACCESSWIRE
EQS Group
  • Published on 11/17/2026 at 23:13, 57 minutes ago

    EQS-Adhoc: M1 Kliniken AG plans move to the Prime Standard in 2027 and raises EBIT margin target for its Beauty segment to at least 25%

  • Published on 11/17/2026 at 22:00, 2 hours 11 minutes ago

    Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social

  • Published on 11/17/2026 at 21:12, 2 hours 58 minutes ago

    EQS-Adhoc: JDC Group AG: Adjustment of Full-Year Guidance

  • Published on 11/17/2026 at 20:21, 3 hours 50 minutes ago

    Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social

  • Published on 11/17/2026 at 20:00, 4 hours 11 minutes ago

    EQS-Adhoc: Sasol Financing USA LLC: SASOL ANNOUNCES RESULTS OF THE INVITATION TO REPURCHASE OUTSTANDING US$750 MILLION 4.5% GUARANTEED SENIOR UNSECURED CONVERTIBLE BONDS DUE 2027

View all EQS
Les Echos
  • Published on 11/17/2026 at 18:00, 6 hours 11 minutes ago

    20261117 - Accor - Accor to increase its stake in Ennismore

  • Published on 11/17/2026 at 18:00, 6 hours 11 minutes ago

    Accor - Accor se renforce au capital de Ennismore

  • Published on 11/17/2026 at 17:45, 6 hours 26 minutes ago

    EURAZEO COMPLETES THE SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT ALONGSIDE PARTNERS GROUP

  • Published on 11/17/2026 at 17:45, 6 hours 26 minutes ago

    EURAZEO FINALISE LA CESSION DE SA PARTICIPATION DANS AROMA-ZONE ET SON REINVESTISSEMENT AUX COTES DE PARTNERS GROUP

  • Published on 11/17/2026 at 07:40, 16 hours 30 minutes ago

    SUEZ INTERNATIONAL SAS COMPLETES THE SALE OF C.10.65 MILLION SHARES OF ACEA S.P.A.

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy